Stockreport

Inventiva announces that screening in the NATiV3, Phase III, clinical trial evaluating lanifibranor in NASH has resumed [Yahoo! Finance]

Inventiva S.A. - American Depository Shares  (IVA) 
PDF Screening of patients is resuming in sites operating under central IRB in the US. Other sites and countries are expected to resume screening and randomization activit [Read more]